Substituted imidazo[1,2-b]pyridazines. New compounds with activity at central and peripheral benzodiazepine receptors.

[1]  K. M. Taylor,et al.  Displacement of [3H] diazepam binding in rat brain by dipyridamole and by 1-methylisoguanosine, a marine natural product with muscle relaxant activity. , 1980, Life sciences.

[2]  J. Richards,et al.  Agonist and antagonist benzodiazepine receptor interaction in vitro , 1981, Nature.

[3]  L. P. Davies,et al.  Purines interact with ‘central’ but not ‘peripheral’ benzodiazepine binding sites , 1982, Neuroscience Letters.

[4]  S. Paul,et al.  An in vitro binding assay which differentiates benzodiazepine 'agonists' and 'antagonists'. , 1982, European journal of pharmacology.

[5]  L. P. Davies,et al.  A purinergic component in the anticonvulsant action of carbamazepine? , 1982, European journal of pharmacology.

[6]  H. Möhler,et al.  Benzodiazepine receptors: differential interaction of benzodiazepine agonists and antagonists after photoaffinity labeling with flunitrazepam. , 1982, European journal of pharmacology.

[7]  H. Yamamura,et al.  Differentiation of benzodiazepine receptor agonist and antagonist: sparing of [3H]benzodiazepine antagonist binding following the photolabelling of benzodiazepine receptors. , 1982, European journal of pharmacology.

[8]  P. Supavilai,et al.  Distinction of benzodiazepine agonists from antagonists by photoaffinity labelling of benzodiazepine receptors in vitro , 1982, Neuroscience Letters.

[9]  L. P. Davies,et al.  Contrasting regulation by GABA of the displacement of benzodiazepine antagonist binding by benzodiazepine agonists and purines , 1982, Neuroscience Letters.

[10]  J. Crawley,et al.  Antagonism of the anxiolytic action of diazepam and chlordiazepoxide by the novel imidazopyridines, EMD 39593 and EMD 41717. , 1983, European journal of pharmacology.

[11]  I. Martin,et al.  Photoaffinity labelling of the benzodiazepine receptor cannot be used to predict ligand efficacy , 1983, Neuroscience Letters.

[12]  M. E. Goldberg,et al.  Novel non-benzodiazepine anxiolytics , 1983, Neuropharmacology.

[13]  L. P. Davies,et al.  Interaction of purines and related compounds with photoaffinity-labelled benzodiazepine receptors in rat brain membranes. , 1984, European journal of pharmacology.

[14]  L. P. Davies.  Pharmacological studies on adenosine analogues isolated from marine organisms , 1985 .

[15]  N. W. Gilman,et al.  III. Conformational shifts at the benzodiazepine receptor related to the binding of agonists antagonists and inverse agonists , 1986 .

[16]  C. Kilpatrick,et al.  Clobazam in the treatment of epilepsy. , 1987, Clinical and experimental neurology.

[17]  B K Koe,et al.  [3H]Ro 15-1788 binding to benzodiazepine receptors in mouse brain in vivo: marked enhancement by GABA agonists and other CNS drugs. , 1987, European journal of pharmacology.

[18]  M. Ngu,et al.  Imidazo[1,2-b]pyridazines. IV. Syntheses and Central Nervous System Activities of Some 3-Methoxy-6-phenoxy(Substituted Phenoxy and Naphthyloxy)-2-phenylimidazo[1,2-b]pyridazines , 1988 .

[19]  M. Ngu,et al.  Imidazo[1,2-B]Pyridazines. III. Syntheses and Central Nervous-System Activities of Some 6-Chloro-3-methoxy (and ethoxy)-2-aryl (and heteroaryl)imidazo[1,2-B]pyridazines , 1988 .

[20]  D. Greenblatt,et al.  'GABA shift' in vivo: enhancement of benzodiazepine binding in vivo by modulation of endogenous GABA. , 1988, European journal of pharmacology.

[21]  M. Ngu,et al.  Imidazo[1,2-b]Pyridazines. VIII. Syntheses and Central Nervous System Activities of Some 6-Benzylamino (and methoxybenzylamino)-3-methoxy-2-phenyl(Substituted phenyl or pyridinyl)imidazo[1,2-b]pyridazines , 1989 .

[22]  L. P. Davies,et al.  Imidazo[1,2-b]pyridazines. VII. Syntheses and Central Nervous System Activities of Some 3-Alkoxy-6-benzyloxy (and methoxy-benzyloxy)-2-phenyl(substituted phenyl or pyridinyl)imidazo[1,2-b]pyridazines , 1989 .

[23]  T. Chiu,et al.  Tolerance to Anticonvulsant Effects of Diazepam, Clonazepam, and Clobazam in Amygdala‐Kindled Rats , 1989, Epilepsia.

[24]  L. P. Davies,et al.  Imidazo[1,2-b]Pyridazines. V. Syntheses and Central Nervous Activities of Some 3-Alkoxy-6-benzylthio(substituted benzylthio and Other phenylalkylthio)-2-phenyl(and substituted phenyl)imidazo[1,2-b]pyridazines , 1989 .

[25]  L. P. Davies,et al.  Imidazo[1,2-b]Pyridazines. VI. Syntheses and Central Nervous System Activities of Some 6-(Alkoxy- and Methylthio-phenoxy and Methoxybenzylthio)-3-methoxy-2-phenyl(substituted phenyl and pyridinyl)Imidazo[1,2-b]pyridazines , 1989 .

[26]  L. P. Davies,et al.  Imidazo[1,2-B]pyridazines. IX. Syntheses and Central Nervous System Activities of Some 3-Alkoxy-6-(o-alkoxy, o-methylthio- or o-fluoro-phenoxy)-2-arylimidazo[1,2-b]pyridazines , 1990 .

[27]  D. Jamieson,et al.  Kava pyrones and resin: studies on GABAA, GABAB and benzodiazepine binding sites in rodent brain. , 1992, Pharmacology & toxicology.

[28]  J. Zhang,et al.  Imidazo[1,2-b]pyridazines. X. Syntheses and Central Nervous System Activities of Some 3-(Acetamido, benzamido, substituted benzamido or dimethylamino)methyl-2-(phenyl or substituted phenyl)-6-(halogeno, alkylthio, alkoxy, phenylthio, phenoxy, benzylthio or benzyloxy)imidazo[1,2-b]pyridazines , 1992 .

[29]  I. Martin,et al.  Multiple benzodiazepine receptors: no reason for anxiety. , 1992, Trends in pharmacological sciences.